Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncolytics Biotech Inc. logo

New insider Aromando Andrew claimed ownership of 25,500 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
ONCY· Oncolytics Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCY (Oncolytics Biotech Inc.) and more on Quantisnow.